Cytoreductive Nephrectomy in the Era of Targeted Therapies: A Review

BJU International - United Kingdom
doi 10.1111/bju.13860
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Wiley

Related search

Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy in the United States: A SEER Analysis

World Journal of Urology
Urology
2012English

Cytoreductive Nephrectomy in the Modern Era: Predictors of Use, Morbidity, and Survival

Canadian Urological Association Journal
Urology
2017English

Cytoreductive Nephrectomy in the Current Treatment Algorithm

Therapeutic Advances in Medical Oncology
Oncology
2019English

A Systematic Review of Pediatric Phase I Trials in Oncology: Toxicity and Outcomes in the Era of Targeted Therapies

Oncologist
Cancer ResearchMedicineOncology
2020English

Trends in the Use of Cytoreductive Nephrectomy in the United States

Clinical Genitourinary Cancer
OncologyUrology
2012English

Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive Nephrectomy

Translational Andrology and Urology
Reproductive MedicineUrology
2016English

Erratum to Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive Nephrectomy

Translational Andrology and Urology
Reproductive MedicineUrology
2016English

Pd04-03 Survival Following Neoadjuvant Targeted Therapy and Cytoreductive Nephrectomy in MRCC Patients With Tumor Thrombus; A Contemporary Multi-Institutional Series

Journal of Urology
Urology
2017English

Determinants of Survival in Advanced Non–Small-Cell Lung Cancer in the Era of Targeted Therapies

Clinical Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy